Diabetes drugs and weight loss - Mayo Clinic
Nov 14, 2024 · GLP-1 agonists mimic the way a hormone called glucagon-like peptide 1 works in the body. When blood sugar starts to rise after a person eats, these medicines cause the body to make more insulin. The extra insulin helps lower blood sugar.
Agonistas del GLP-1: fármacos para la diabetes y pérdida de peso
Mar 7, 2025 · ¿Hay fármacos para la diabetes tipo 2 que pueden ayudar a las personas a bajar de peso y a reducir su nivel de azúcar en sangre? ¿Hay efectos secundarios? Respuesta de M. Regina Castro, M.D. Hay una clase de medicamentos para la diabetes tipo 2 que no solo mejora el control de la glucosa en la ...
GLP-1 激动剂：糖尿病药物和减重 - 妙佑医疗国际
Feb 21, 2025 · 这类药物通常被称为胰高血糖素样肽 1（glp-1）激动剂。 另一类可能帮助减重并改善血糖控制的药物是钠葡萄糖耦联转运体 2（SGLT-2）抑制剂。 卡格列净（Invokana）、埃格列净（Steglatro）、达格列净（Farxiga）和恩格列净（Jardiance）都属于这类药物。
ناهضات GLP-1: عقاقير مرض السكري وفقدان الوزن - Mayo Clinic (مايو كلينك)
ويُطلق على هذه الفئة من الأدوية عادةً ناهضات الببتيد المشابه للغلوكاجون 1 (glp-1). كذلك تتوفر فئة أخرى من الأدوية قد تساعد في تخفيف الوزن وتحسين التحكم في نسبة السكر في الدم، وهي مثبطات الناقل ...
glp-1 受体激动剂降糖作用机制是什么？ - 知乎
glp-1这个蛋白就比较神奇，它的全称叫"胰高血糖素样肽-1"，是一种肠道中产生的激素，能够在高血糖时刺激胰岛素大量分泌，注意是在"高血糖"的时候，所以就比单纯注射胰岛素好了很多，因为当血糖下降到正常水平后再激活glp-1的受体也不会继续增加胰岛素的 ...
Diagnosis and management of patients with gastroparesis
Jan 25, 2022 · Other conditions and factors associated with gastroparesis include type 1 and type 2 diabetes mellitus, medications that impair gastric emptying (most notably opioids, GLP-1 agonists used for diabetes and tricyclic antidepressants at high doses), neurological disorders, and autoimmune disorders.
Liraglutide (subcutaneous route) - Mayo Clinic
Feb 1, 2025 · Liraglutide injection is used with diet and exercise to lower blood sugar in people with type 2 diabetes. It is also used to reduce the risk of life-threatening events, including heart attack and stroke, in adults with type 2 diabetes and established heart or blood vessel disease. This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist.
Semaglutide (subcutaneous route) - Mayo Clinic
Mar 1, 2025 · Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist. Semaglutide injection is also used together with diet and exercise to help lose weight and keep the weight off in patients with at least one weight-related medical condition.
首个国产GLP-1「减肥神药」来了，华东医药利拉鲁肽获批，哪些 …
glp⁃1是一种由 30个氨基酸组成的肠促胰岛素激素，餐后由我们人体的回肠远端、结肠近端和迷走神经的l细胞分泌，具有降糖和减重的作用。 但是天然GLP⁃1半衰期很短，仅为1-2分钟，它在血液循环中很快会被二肽基肽酶⁃4（DPP⁃4）快速分解而失去活性。
Semaglutide (oral route) - Mayo Clinic
Mar 1, 2025 · Semaglutide is used to treat type 2 diabetes. It is used together with diet and exercise to help control your blood sugar. This medicine is a glucagon-like peptide-1 (GLP-1) receptor agonist. This medicine is available only with your doctor's prescription.